Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9530]
News [23409]
Articles [1991]
Editorials [134]
Conferences [465]
elearning [298]
Anastrozole cuts breast cancer cases by more than 50% in high risk women
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Anastrozole cuts breast cancer cases by more than 50% in high risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
13 Dec 2013
Patients with metastatic breast cancer may not benefit from surgery and...
Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India.
Patients with metastatic breast cancer may not benefit from surgery and radiation after chemotherapy ( Dr Rajendra Badwe - Tata Memorial Hospital, Mumbai, India. )
13 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Full-intensity transplantation and short telomeres increase risk of cognitive...
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA
Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA )
13 Dec 2013
Targeting tyrosine kinase receptors to tackle CML
Prof Michael Deininger - University of Utah, Salt Lake City, USA
Targeting tyrosine kinase receptors to tackle CML ( Prof Michael Deininger - University of Utah, Salt Lake City, USA )
13 Dec 2013
Chronic lymphocytic leukaemia: A new treatment era is born
Dr John Gribben - Barts Cancer Institute, London, UK
Chronic lymphocytic leukaemia: A new treatment era is born ( Dr John Gribben - Barts Cancer Institute, London, UK )
13 Dec 2013
Chemo-free treatment for acute promyelocytic leukaemia
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Chemo-free treatment for acute promyelocytic leukaemia ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
13 Dec 2013
Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels...
Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA
Comment on HER2 research: NeoALTTO trial, BETH study and immune cell levels predicting outcomes ( Dr Jennifer Litton - MD Anderson Cancer Center, Houston, USA )
12 Dec 2013
NeoALTTO trial indicates breast cancer patients who had pathologic complete...
Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium
NeoALTTO trial indicates breast cancer patients who had pathologic complete response had improved event-free and overall survival ( Prof Martine Piccart-Gebhart - Jules Bordet Institute, Brussels, Belgium )
12 Dec 2013
Immune cells in tumours may identify breast cancer patients most likely to...
Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab ( Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2013
BETH study: highly effective treatment option for patients with HER2 breast...
Dr Dennis Slamon - University of California, Los Angeles
BETH study: highly effective treatment option for patients with HER2 breast cancer ( Dr Dennis Slamon - University of California, Los Angeles )
12 Dec 2013
Screening mammography, over diagnosis and over treatment
Dr Gilbert Welch - Dartmouth College, Hanover, USA
Screening mammography, over diagnosis and over treatment ( Dr Gilbert Welch - Dartmouth College, Hanover, USA )
12 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation